The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy

The use of azathioprine in Crohn’s disease during pregnancy and in the post-operative setting: a worldwide survey of experts

(2011) L. Peyrin-Biroulet et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Guidelines for the management of inflammatory bowel disease in adults

(2011) C. Mowat et al.   GUT

The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD)

(2011) Lisa Shim et al.   Journal of Crohns & Colitis

Managing pregnancy in inflammatory rheumatological diseases

(2011) Varsha Jain et al.   ARTHRITIS RESEARCH & THERAPY

A safety assessment of tumor necrosis factor antagonists during pregnancy

(2010) Vanessa C Osting et al.   Expert Opinion On Drug Safety

Inflammatory bowel disease and pregnancy: an update

(2010) Lola Y Kwan et al.   Expert Review of Clinical Immunology

Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study

(2010) J. Coelho et al.   GUT

Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding

(2010) Sieglinde Angelberger et al.   Journal of Crohns & Colitis

Early pregnancy azathioprine use and pregnancy outcomes

(2009) Brian J. Cleary et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Pregnancy and IBD treatment: This challenging interplay from a patients' perspective

(2009) R.E. Mountifield et al.   Journal of Crohns & Colitis

Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: A meta-analysis

(2007) Roja Rahimi et al.   REPRODUCTIVE TOXICOLOGY